Treatment approaches for dual diagnosis clients in England

Drug and Alcohol Review

Volumn 27, Issue 6, 2008, Pages 650-658

  Schulte, Sabrina J ^a   Meier, Petra S ^b   Stirling, John ^a   Berry, Mike ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Co morbidity; Dual diagnosis; Joint working; Prevalence; Treatment approaches

Indexed keywords

ADDICTION; ADULT; ARTICLE; DRUG DEPENDENCE TREATMENT; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PATIENT CARE; PREVALENCE; PSYCHIATRIC DIAGNOSIS; PUBLIC RELATIONS; QUESTIONNAIRE; TREATMENT OUTCOME; UNITED KINGDOM; URBAN POPULATION; UTILIZATION REVIEW;

ADULT; DIAGNOSIS, DUAL (PSYCHIATRY); ENGLAND; FEMALE; HEALTH CARE SURVEYS; HUMANS; INTERINSTITUTIONAL RELATIONS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT CARE TEAM; PREVALENCE; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; URBAN POPULATION;

EID: 56749152126     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230802392816     Document Type: Article

References (74)

1. Drake R, Osher F, Wallach M. Alcohol use and abuse in schizophrenia; a prospective community study. J Nerv Ment Dis 1989;177:408-14.
2. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990;264:2511-18.
3. Mueser K, Bellack A, Blanchard J. Comorbidity of schizophrenia and substance abuse. J Clin Chiropract Pediatr 1992;60:845-56.
4. Kendler KS, Davis CG, Kessler RC. The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history. Br J Psychiatry 1997;170:541-8.
5. Bartu A, Freeman N, Gawthorne G, Codde J, Holman CDJ. Psychiatric comorbidity in a cohort of heroin and amphetamine users in Perth, Western Australia. J Subst Use 2003;8:150-4.
6. Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res 2004;67:157-66.
7. Bakken K, Landheim AS, Vaglum P. Substance-dependent patients with and without social anxiety disorder: occurrence and clinical differences: a study of a consecutive sample of alcohol-dependent and poly-substance-dependent patients treated in two counties in Norway. Drug Alcohol Depend 2005;80:321-8.
8. Duke P, Pantelis C, Barnes T. South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry 1994;164:630-36.
9. Menezes P, Johnson S, Thornicroft G, et al. Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry 1996;168:612-19.
10. Crome I. Overview: psychiatric comorbidity and substance misuse: what are the issues? Drugs Educ Prev Policy 1999;6:149-50.
11. Afuwape S. Where are we with dual diagnosis (substance misuse and mental illness)? A review of the literature. London: Rethink, 2003.
12. Drake R, Osher F, Wallach M. Alcohol use and abuse in schizophrenia; a prospective community study. J Nerv Ment Dis 1989;177:408-14.
13. Linszen D, Dingemans P, Lenior M. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994;51:273-79.
14. Scott H, Johnson S, Menezes P, et al. Substance misuse and risk of aggression and offending among the severely mentally ill. Br J Psychiatry 1998;172:345-50.
15. Kamali M, Kelly L, Gervin M, Browne S, Larkin C, O'Callaghan E. The prevalence of comorbid substance misuse and its influence on suicidal ideation among in patients with schizophrenia. Acta Psychiatr Scand 2000;101:452-56.
16. Johnson J. Cost-effectiveness of mental health services for persons with a dual diagnosis: a literature review and the CCMHCP. J Subst Abuse Treat 2000;18:119-28.
17. Drake R, Mueser K. Psychosocial approaches to dual diagnosis. Schizophr Bull 2000;26:105-18.
18. Drake R, Mercer-McFadden C, Mueser K, McHugo G, Bond G. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998;24:589-608.
19. Jeffery DP, Ley A, McLaren S, Siegfried N. Psychosocial treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2000;Issue 2:CD001088. DOI: 10.1002/14651858. CD001088.
20. Donald M, Dower J, Kavanagh D. Integrated versus non-integrated management and care for clients with cooccurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials. Soc Sei Med 2005;60:1371-83.
21. Tiet Q, Mausbach B. Treatments for patients with dual diagnosis: a review. Alcohol Clin Exp Res 2007;31:513-36.
22. Phillips P, Johnson S. Drug and alcohol misuse among inpatients with psychotic illnesses in three inner-London psychiatric units. Psychiatr Bull 2003;27:217-20.
23. Barnes T, Mutsatsa S, Hutton S, Watt H, Joyce E. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry 2006;188:237-42.
24. Duke P, Pantelis C, McPhillips M, Barnes T. Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London. Br J Psychiatry 2001;179:509-13.
25. Holland M. How substance use affects people with mental illness. Nurs Times 1999;95:46-8.
26. Wright S, Gournay K, Glorney E, Thornicroft G. Dual diagnosis in the suburbs: prevalence, need, and in-patient service use. Soc Psychiatry Psychiatr Epidemiol 2000;35: 297-304.
27. Graham H, Maslin J, Copello A, et al. Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. Soc Psychiatry Psychiatr Epidemiol 2001;36:448-55.
28. Virgo N, Bennett G, Higgins D, Bennett L, Thomas P. The prevalence and characteristics of co-occurring serious mental illness (SMI) and substance abuse or dependence in the patients of Adult Mental Health and Addictions Services in eastern Dorset. J Ment Health 2001;10:175-88.
29. Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence: intake data from the National Treatment Outcome Research Study. Br J Psychiatry 2000; 176:285-9.
30. Weaver T, Hickman M, Rutter D, Ward J, Stimson G, Renton A. The prevalence and management of co-morbid substance misuse and mental illness: results of a screening survey in substance misuse and mental health treatment populations. Drug Alcohol Rev 2001;20:407-16.
31. Strathdee G, Manning V, Best D, et al. Dual diagnosis in a primary care group (PCG): a step-by-step epidemiological needs assessment and design of a training and service response model. London: Department of Health, 2002.
32. Ley A, Jeffrey D, Ruiz J, McLaren S, Gillespie C. Underdetection of comorbid drug use in acute psychatric admission. Psychiatr Bull 2002;26:248-51.
33. Tarrier N, Sommerfield C. Alcohol and substance use in civilian chronic PTSD patients seeking psychological treatment. J Subst Use 2003;8:197-204.
34. Mueser K, Drake R, Wallach M. Dual diagnosis: a review of etiological theories. Addict Behav 1998;23:717-34.
35. MacGregor S. Messages and findings from the Department of Health drugs misuse research initiative: final overview report. Drugs Educ Prev Policy 2005;12:1-136.
36. Crawford V, Crome I, Clancy C. Co-existing problems of mental health and substance misuse (dual diagnosis): a literature review. Drugs Educ Prev Policy 2003;10:1-74.
37. Graham H, Copello A, Birchwood M, et al. Service innovations: coexisting severe mental health and substance use problems: developing integrated services in the UK. Psychiatr Bull 2003;27:183-6.
38. Gonzales J, Insel T. The conundrum of co-occurring mental and substance use disorders: opportunities for research. Biol Psychiatry 2004;56:723-5.
39. Kay-Lambkin F, Baker A, Lewin T. The 'co-morbidity roundabout': a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems. Drug Alcohol Rev 2004;23:407-23.
40. Lowe A, Abou-Saleh M. The British experience of dual diagnosis in the national health service. Acta Neuropsychiatry 2004;16:41-6.
41. Minkoff, K. An integrated model for the management of cooccurring psychiatric and substance disorders in managedcare systems. Dis Manage Health Outcomes 2000;8:251-7.
42. Health Advisory Service. Substance misuse and mental health co-morbidity (dual diagnosis). Standards for mental health services. London: Health Advisory Service, 2001.
43. Department of Health.Mental health policy implementation guide: dual diagnosis good practice guide. London: Department of Health, 2002.
44. National Treatment Agency of Substance Misuse. Models of care for the treatment of drug misusers. Part 2: Full reference report. London: National Treatment Agency for Substance Misuse, 2002.
45. Barreira P, Espey B, Fishbein R, Moran D, Flannery R. Linking substance abuse and serious mental illness service delivery systems: initiating a statewide collaborative. J Behav Health Serv Res 2000;27:107-13.
46. Grella C, Gilmore J. Improving service delivery to the dually diagnosed in Los Angeles County. J Subst Abuse Treat 2002;23:115-22.
47. Gil-Rivas V, Grella C. Addictions services treatment services and service delivery models for dually diagnosed clients: variations across mental health and substance abuseproviders. Commun Ment Health J 2005;41:251-66.
48. Moggi F, Ouimette P, Moos R, Finney J. Dual diagnosis patients in substance abuse treatment: relationship of general coping and substance-specific coping to 1-year outcomes. Addiction 1999;94:1805-16.
49. Drake R, Morse G, Brunette M, Torrey W. Evolving U.S. service model for patients with severe mental illness and cooccurring substance use disorder. Acta Neuropsychiatry 2004;16:36-40.
50. Martino S, Carroll K, Nich C, Rounsaville B. A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction 2006;101:1479-92.
51. Appleby L. The national service framework for mental health-five years on. London: Department of Health, 2004.
52. Ley A, Jeffery D, McLaren S, Siegfried N. Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2006;36; Issue 2:CD001088.
53. Available at: http://drugscope.soutron.com/helpfinder.asp (accessed 5 December 2005).
54. Drugscope. Drug problems: where to get help. Directory of services. London: DrugScope, 2002.
55. Available at: http://talktofrank.com/home-html.aspx (accessed 5 December 2005).
56. Day E, Ison J, Keaney F, Buntwal N, Strang J. A national survey of inpatient drug treatment services in England. London: National Treatment Agency, 2005.
57. SPSS, Inc. SPSS for Windows, version 12.0.1. Chicago, IL: SPSS, 2001.
58. Weber RP. Basic Content Analysis, 2nd edn. Newbury Park, CA: Sage publications, 1990.
59. Mathers D, Ghodse A, Caan A, Scott S. Cannabis use in a large sample of acute psychiatric admissions. Br J Addict 1991;86:779-84.
60. Weaver T, Madden P, Charles V, et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003;183:304-13.
61. Kidorf M, Disney ER, King VL, Neufeld K, Beilenson BL, Brooner RK. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend 2004;74:115-22.
62. Bauer MS, Altshuler L, Evans DR, Beresford T, Williford TE, Hauger R. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord 2005; 85:301-15.
63. Rush AJ, Zimmermann M, Wisniewski SR, et al. Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features. J Affect Disord 2005;87: 43-5.
64. Soyka M, Albus M, Immler B, Kathmann N, Hippius H. Psychopathology in dual-diagnosis and nonaddicted schizophrenics: are there differences? Eur J Health Econ 2002;3: 114-20.
65. Gual A. Dual diagnosis in Spain. Drug Alcohol Rev 2007;26:65-71.
66. Hides L, Dawe S, Young R, Kavanagh D. The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis. Addiction 2007;102:35-40.
67. Phillips P. The mad, the bad and the dangerous-harm reduction in dual diagnosis. Int J Drug Policy 1998;9:345-9.
68. Brown V, Melchior L, Huba G. Level of burden among women diagnosed with severe mental illness and substance abuse. J Psychoact Drugs 1999;31:31-40.
69. Moos R, Finney J, Federman E, Suchinsky R. Specialty mental health care improves patients' outcomes: findings from a nationwide program to monitor the quality of care for patients with substance use disorders. J Stud Alcohol 2000;61:704-13.
70. Department of Health. Dual diagnosis in mental health inpatient and day hospital settings. London: Department of Health, 2006.
71. Deans C, Soar R. Caring for clients with dual diagnosis in rural communities in Australia: the experience of mental health professionals. J Psychiatr Ment Health Nurs 2005;12: 268-74.
72. Maslin J, Graham H, Cawley M, et al. Combined severe mental health and substance use problems: what are the training and support needs of staff working with this client group? J Ment Health 2001;10:131-40.
73. Mears A, Clancy C, Banerjee S, Crome I, Agbo-Quaye S. Co-existing problems of mental disorder and substance misuse (dual diagnosis): a training needs analysis. Final report to the Department of Health. London: Royal College of Psychiatrists' Research Unit, 2001.
74. Richmond I, Foster J. Negative attitudes towards people with co-morbid mental health and substance misusers problems: an investigation of mental health professionals. J Ment Health 2003;12:393-403.